% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • rojospan rojospan Apr 22, 2013 12:29 AM Flag

    $ 294000x 30000= 8.8 B X5= 44 B market cap


    Just VX 770 potential for Delta 508 homozygous

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seriously? With healthcare reform, the US government is going to dole out almost $300k per year for a chronic treatment and not a cure? We are still 2-3 years away to find out. So you don't mind locking up your money til then. Oh and by the way, during that time the HCV sales will get nipped away as each one of its competitors launches new HCV drugs. Gilead already submitted its med earlier this month. And unlike CF, when patients with hep C retain levels below 25iu/ml 6 months after cessation of treatment, they are considered cured. The reimbursement for this "cure" is ~$50k. So you really think the reimbursement for a chronic treatment will be 6X?

89.19-0.37(-0.41%)May 26 4:00 PMEDT